Moderna says COVID vaccine 'highly effective' in adolescents
Published
U.S. biotech firm Moderna said Tuesday that trials had shown its COVID-19 vaccine is "highly effective" in adolescents aged 12-17 and the company would seek regulators' approval in…
Full Article